| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emmaus Life Sciences, Inc. (EMMA) has 0 insiders with recent SEC Form 4 filings, including 18 buys and 0 sells. EMMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2020 | Lee Willis C | Vice Chairman &COO | Buy | 3,000 | $1.77 | $5,305.00 | +0.7% | |
| Feb 12, 2020 | Niihara Yutaka | Chairman And CEO | Buy | 31,100 | $1.80 | $56,116.00 | +0.1% | |
| Feb 7, 2020 | Niihara Yutaka | Chairman And CEO | Buy | 18,800 | $1.28 | $23,998.00 | - | |
| Feb 7, 2020 | Lee Willis C | Vice Chairman &COO | Buy | 4,550 | $1.31 | $5,960.50 | +1.1% | |
| Nov 1, 2019 | Niihara Yutaka | Chairman And CEO | Buy | 16,500 | $2.98 | $49,170.00 | +0.2% | |
| Nov 1, 2019 | Lee Willis C | Vice Chairman &COO | Buy | 1,800 | $2.94 | $5,284.00 | +0.4% | |
| Oct 31, 2019 | Niihara Yutaka | Chairman And CEO | Buy | 5,500 | $2.69 | $14,815.00 | - | |
| Oct 18, 2019 | Niihara Yutaka | Chairman And CEO | Buy | 7,000 | $2.78 | $19,460.00 | - | |
| Oct 18, 2019 | Lee Willis C | Vice Chairman &COO | Buy | 7,890 | $2.65 | $20,893.10 | +2.0% | |
| Oct 16, 2019 | Niihara Yutaka | Chairman And CEO | Buy | 6,500 | $2.72 | $17,680.00 | - |